Sentences with phrase «few leading cancer»

«There are few leading cancer centers where clinical trials and new cutting - edge therapies are leading the fight against cancer, and City of Hope is one of the very best in the world.

Not exact matches

Zymeworks will be putting its two leading drug candidates, both targeted at breast cancer, into clinical trials in the next few months.

Celgene's lead product, Revlimid, a drug designed to treat multiple myeloma and a few other cancer types, has been benefiting from longer duration of use, strong pricing power, and high multiple myeloma market share.

Anybody with open eyes can see that this is not true, except for a few things like smoking leading to lung cancer.

Approximately 175000 cancer cases are diagnosed annually in children younger than age 15 years worldwide, 1 with an annual increase of around 0.9 % in incidence rate in the developed world, only partly explained by improved diagnosis and reporting.1, 2 Childhood cancer is rare and its survival rate has increased significantly over the years owing to advancement in treatment technologies; however, it is still a leading cause of death among children and adolescents in developed countries, ranking second among children aged 1 to 14 years in the United States, surpassed only by accidents.1, 3 Childhood cancer is also emerging as a major cause of death in the last few years in Asia, Central and South America, Northwest Africa, and the Middle East, where death rates from preventable communicable diseases are declining.2

In 2006, a team led by Joseph DeRisi, a biochemist at the Howard Hughes Medical Institute in San Francisco, examined prostate cancers for viruses and found that a few of the samples contained a new virus closely related to xenotropic murine leukaemia virus (XMRV), which is known to cause cancer in mice.

«Randomized trials have confirmed the value of radiation dose escalation for prostate tumors, and the potential benefits of larger radiation doses in fewer fractions, are expected to increase the therapeutic efficacy for men with prostate cancer,» said Anders Widmark, MD, a professor of radiation sciences at Umeå University in Umeå, Sweden and lead author of the study.

Edward Messing, the senior author of the study, says that PSA is capable of detecting the disease earlier, which could, in theory lead to fewer deaths from prostate cancer.

Nursing improves bone strength (leading to fewer hip fractures in postmenopausal women) and reduces the risk of ovarian cancer and premenopausal breast cancer.

Though the optimal scenario is actually estimated to catch fewer lung cancers than the criteria used in the National Lung Screening Trial (NLST) in the US, the authors predict this more stringent scenario would require fewer CT scans, and lead to fewer false positive screens and lung cancer overdiagnosis, which can lead to patient harm.

Professor Sadler comments that this research could lead to new cancer treatments: «Cancer drugs with new mechanisms of actions which can combat resistance and have fewer side - effects are urgently ncancer treatments: «Cancer drugs with new mechanisms of actions which can combat resistance and have fewer side - effects are urgently nCancer drugs with new mechanisms of actions which can combat resistance and have fewer side - effects are urgently needed.

«With head and neck cancer, we often clear patients of cancer only to see it come back with deadly consequences a few years later,» said lead author Julie Bauman, M.D., M.P.H., co-director of the UPMC Head and Neck Cancer Center of Excelcancer, we often clear patients of cancer only to see it come back with deadly consequences a few years later,» said lead author Julie Bauman, M.D., M.P.H., co-director of the UPMC Head and Neck Cancer Center of Excelcancer only to see it come back with deadly consequences a few years later,» said lead author Julie Bauman, M.D., M.P.H., co-director of the UPMC Head and Neck Cancer Center of ExcelCancer Center of Excellence.

«This study, one of only a few large studies to have follow - up beyond five years, demonstrates that patients who have head and neck cancers and who are being treated with radiation therapy alone have improved local - regional control and no increase in late toxicity when radiation therapy is delivered twice a day in two smaller doses which we call hyperfractionation,» said Jonathan J. Beitler, MD, MBA, FASTRO, lead author of the study and professor of radiation oncology, otolaryngology and hematology / medical oncology at the Winship Cancer Institute of Emory University School of Medicine in Atlanta.

The findings at the Fred Hutch - led Women's Health Initiative resulted in a change in menopause treatment that means 20,000 fewer women worldwide are diagnosed with breast cancer every year.

That search led to a contact at Johns Hopkins University, and a few days later, Joho got a call from a cancer geneticist co-leading a study there.

To cite a few instances, polymerase chain reaction (PCR), a molecular method developed over three decades ago, has been widely applied in disease diagnosis, disease mechanism deciphering, and prognosis prediction; the elucidation of tyrosine kinase activity in cancer cells has led to the development of novel drugs for cancer treatment; and the identification of proteins and genetic molecules by molecular methods as biomarkers for disease diagnosis and prognosis has been drawing great interest.

«Our work suggests it might be possible to halt cancer development in premalignant cells - those that are just a few divisions away from being normal,» says the study's lead author, Fernando Lopez - Diaz, a researcher in the Regulatory Biology Laboratory at Salk.

Lead study author Dr Keith Flaherty, director of developmental therapeutics at the MGH Cancer Centre, commented: «Until now, available therapies [for advanced melanoma] were few and unreliable.

«Given that aspirin is a cheap, off - patent drug with relatively few side effects, this will have a great impact on health care systems as well as patients,» study lead author Dr. Martine Frouws, of Leiden University Medical Center in the Netherlands, said in a news release from the European Cancer Congress (ECC).

There are even provocative data suggesting that combining this FMD with cancer chemotherapy may lead to improved success and fewer side effects.

For instance, the 2001 Physicians Health Study of more than 20,000 men found that having more than 2.5 servings of dairy per day led to a 34 % greater risk of developing prostate cancer, compared to consuming 0.5 or fewer servings per day (7).

These phytonutrients work as antioxidants in our body fighting off free radicals and the damage they cause which can lead to a whole host of chronic diseases including cancer, cardiovascular disease, autoimmune conditions like rheumatoid arthritis and neurodegenerative diseases like Alzheimer's to name a few.

Excess dietary protein can lead to elevated blood sugar, weight gain, kidney stress, leaching of bone minerals, and stimulation of cancer cells, and it's easy to overdo it if you eat a few handfuls of high - protein nuts.

Using full - fat dairy will also lower your cholesterol and prevent cancer, prevent diabetes and heart disease, and the cholesterol in full - fat dairy helps your body manufacture hormones that leads to fewer PMS symptoms.

While e-cigarettes typically have fewer chemicals than regular cigarettes, they may still contain heavy metals like lead, flavorings linked to lung disease, small particles that can be inhaled deep into the lungs, and cancer - causing chemicals.

Jayme: There are the usual suspects: parabens, phthalates, and sodium lauryl and laureth sulfate, which all lead to skin irritation and a few have been linked to cancer and endocrine disruption.

There are a few possible causes for the symptoms you are describing, but without an examination I can not say what the cause is with any certainty; vertebral issues (luxation, intervertebral disk disease etc...), trauma, poisoning, liver disease, kidney disease, cancer among other causes may be leading to these symptoms.

She has been dubbed «the glue» by previous clients, having worked with large leading edge organizations in North America, such as tech startup HeroX.com, BC Cancer Research and ACT Medical to name a few.